Subscribe To
NVAX / Are These 2 Companies Next for Short Squeezes?
NVAX News
By Invezz
November 3, 2023
Novavax could become a penny stock: beware of the Wyckoff theory
Novavax (NASDAQ: NVAX) stock price has been a huge disappointment among investors in the past few months. After peaking at $332 during the Covid-19 pa more_horizontal
By PRNewsWire
November 2, 2023
Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023
GAITHERSBURG, Md. , Nov. 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ more_horizontal
By Reuters
October 16, 2023
Novavax positive on updated COVID vaccine availability in US
Novavax said on Monday it was "encouraged" by the broad availability of its updated COVID-19 vaccine being rolled out in the U.S., days after rival Pf more_horizontal
By The Motley Fool
October 16, 2023
Is Novavax Stock a Buy Now?
Novavax's coronavirus vaccine is one of the few currently authorized in the U.S. However, the company's competition is fierce in a market whose size i more_horizontal
By Reuters
October 15, 2023
EU delays approval of Novavax's revised COVID vaccine - FT
European Union (EU) regulators have delayed the decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the Financial Times said on more_horizontal
By InvestorPlace
October 13, 2023
Novavax (NVAX) Stock Slides Despite Vaccine Availability
Despite seemingly good news, shares of biotechnology firm Novavax (NASDAQ: NVAX ) suffered a significant decline. Earlier Friday morning, management a more_horizontal
By Reuters
October 13, 2023
Novavax's updated COVID-19 vaccines available in US pharmacies
Novavax said on Friday its updated COVID-19 vaccine was available across pharmacies in the United States. more_horizontal
By Zacks Investment Research
October 10, 2023
Novavax (NVAX) Focuses on Diversifying Vaccines Portfolio
Owing to the slow uptake of Novavax's (NVAX) COVID-19 vaccine, the company is trying to develop other vaccine candidates targeting different indicatio more_horizontal